Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000929638-09-001369
Filing Date
2009-08-17
Accepted
2009-08-17 17:25:55
Documents
1
Group Members
BAM CAPITAL, LLCBAM MANAGEMENT, LLCHAL MINTZROSS BERMAN

Document Format Files

Seq Description Document Type Size
1 biosante_sch13g.htm SC 13G 177841
  Complete submission text file 0000929638-09-001369.txt   179983
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Subject) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-60689 | Film No.: 091020072
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 44 WALL STREET SUITE 1603 NEW YORK NY 10005
Business Address 44 WALL STREET SUITE 1603 NEW YORK NY 10005 646-307-4503
BAM Opportunity Fund, L.P. (Filed by) CIK: 0001433768 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G